Semaglutide A GLP-1 receptor agonist that mimics a natural hormone in your body to control appetite and blood sugar Administered as a weekly injection Proven effective for weight loss in clinical trials Also approved for type 2 diabetes management Tirzepatide Dual GLP-1/GIP receptor agonist, meaning it targets two key hormones for even greater potential weight loss
Without insurance coverage, its higher cost, compared to SMBG, can impose a financial burden on PwD
These findings support the real-world therapeutic effectiveness of oral semaglutide outside highly controlled clinical trials
Last time we learned how to Build a Bigger Back with Mike Israetel
Better Snack Alternatives to Consider on Tirzepatide If you find popcorn causes nausea, bloating, or unhelpful cravings despite its low calorie count, protein-rich alternatives often provide superior satiety with less volume
Branched-chain amino acid metabolism in cancer